Abstract

ObjectivesTo differentiate Glioblastomas (GBM) and Brain Metastases (BM) using a radiomic features-based Machine Learning (ML) classifier trained from post-contrast three-dimensional T1-weighted (post-contrast 3DT1) MR imaging, and compare its performance in medical diagnosis versus human experts, on a testing cohort.MethodsWe enrolled 143 patients (71 GBM and 72 BM) in a retrospective bicentric study from January 2010 to May 2019 to train the classifier. Post-contrast 3DT1 MR images were performed on a 3-Tesla MR unit and 100 radiomic features were extracted. Selection and optimization of the Machine Learning (ML) classifier was performed using a nested cross-validation. Sensitivity, specificity, balanced accuracy, and area under the receiver operating characteristic curve (AUC) were calculated as performance metrics. The model final performance was cross-validated, then evaluated on a test set of 37 patients, and compared to human blind reading using a McNemar’s test.ResultsThe ML classifier had a mean [95% confidence interval] sensitivity of 85% [77; 94], a specificity of 87% [78; 97], a balanced accuracy of 86% [80; 92], and an AUC of 92% [87; 97] with cross-validation. Sensitivity, specificity, balanced accuracy and AUC were equal to 75, 86, 80 and 85% on the test set. Sphericity 3D radiomic index highlighted the highest coefficient in the logistic regression model. There were no statistical significant differences observed between the performance of the classifier and the experts’ blinded examination.ConclusionsThe proposed diagnostic support system based on radiomic features extracted from post-contrast 3DT1 MR images helps in differentiating solitary BM from GBM with high diagnosis performance and generalizability.

Highlights

  • Brain Metastases (BM) and Glioblastomas (GBM) are the two most frequent intra-cranial brain tumors in adults [1,2,3]

  • Exclusion criteria for the training set were: 1) lesions less than 2 cm, 2) extra-axial locations, 3) history of treatment before the Magnetic Resonance Imaging (MRI) examination, 4) absence of 3D T1-weighted Fast SPoiled Gradient Recalled sequence, 5) image acquisition performed on a different machine to the 3 Tesla GE Discovery MR scanner, and 6) 3D T1weighted sequence acquired with non-conventional parameters or inadequate quality

  • 267 GBM and 271 BM were pre-selected for the training set, and 71 GBM and 72 BM met the inclusion criteria respectively (Figure 2)

Read more

Summary

Introduction

Brain Metastases (BM) and Glioblastomas (GBM) are the two most frequent intra-cranial brain tumors in adults [1,2,3]. BM present an encapsulated contrast enhancement, with regular and welldefined boundaries, whereas GBM have heterogeneous contrast enhancement with very irregular and fuzzy boundaries [4,5,6] Their morphological characteristics remain very similar on MRI as both are lesions with annular contrast enhancement, having a necrotic center and a peritumoral zone in T2-weighted and Fluid-Attenuated Inversion Recovery (FLAIR) sequences. Advanced neuroimaging techniques such as perfusion MRI and Magnetic Resonance Spectroscopy (MRS) provide additional information to distinguish between the two tumor types, based on differences in the peritumoral area [7,8,9,10]. A strong emphasis was placed on favoring explainable classifiers to ease translation into clinic

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call